Evidence map›Paper›PMID 32106856›Full record

SynthesisWorld journal of surgical oncology2020

Systematic review and meta-analysis of video-assisted thoracoscopic surgery segmentectomy versus lobectomy for stage I non-small cell lung cancer.

Weibiao Zeng, Wenxiong Zhang, Jianyong Zhang, Guangmiao You, Yu'ang Mao, Jianjun Xu, Dongliang Yu, Jinhua Peng, Yiping Wei

Open access · goldAbstract readComparative StudyMeta-AnalysisSystematic Review
In one paragraph

Synthesis in World journal of surgical oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Segmentectomy versus lobectomy. Which factors are decisive for an optimal oncological outcome?Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery · 2023
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Weibiao ZengDepartment of Cardiothoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Wenxiong ZhangDepartment of Cardiothoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Jianyong ZhangDepartment of General Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou Province, China.
Guangmiao YouDepartment of Cardiothoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Yu'ang MaoDepartment of Cardiothoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Jianjun XuDepartment of Cardiothoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Dongliang YuDepartment of Cardiothoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Jinhua PengDepartment of Cardiothoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Yiping WeiDepartment of Cardiothoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China. weiyip2000@hotmail.com.ORCID http://orcid.org/0000-0002-5087-7113
Nanchang University · CNGuiyang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWhether video-assisted thoracoscopic surgery (VATS) segmentectomy and VATS lobectomy provide similar perioperative and oncological outcomes in stage I non-small cell lung cancer (NSCLC) is still controversial.

methodsMeta-analysis of 12 studies comparing outcomes after VATS lobectomy and VATS segmentectomy for stage I NSCLC. Data were analyzed by the RevMan 5.3 software.

resultsDisease-free survival (HR 1.19, 95% CI 0.89 to 1.33, P = 0.39), overall survival (HR 1.11, 95% CI 0.89 to 1.38, P = 0.36), postoperative complications (OR = 1.10, 95% CI 0.69 to 1.75, P = 0.7), intraoperative blood loss (MD = 3.87, 95% CI - 10.21 to 17.94, P = 0.59), operative time (MD = 10.89, 95% CI - 13.04 to 34.82, P = 0.37), air leak > 5 days (OR = 1.20, 95% CI 0.66 to 2.17, P = 0.55), and in-hospital mortality (OR = 1.67, 95% CI 0.39 to 7.16, P = 0.49) were comparable between the groups. Postoperative hospital stay (MD = - 0.69, 95% CI - 1.19 to - 0.19, P = 0.007) and number of dissected lymph nodes (MD = - 6.44, 95%CI - 9.49 to - 3.40, P < 0.0001) were significantly lower in VATS segmentectomy patients.

conclusionsVATS segmentectomy and VATS lobectomy provide similar oncological and perioperative outcomes for stage I NSCLC patients. This systematic review was registered on PROSPERO and can be accessed at http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID = CRD42019133398.

Indexed as

Blood Loss, SurgicalCarcinoma, Non-Small-Cell LungDisease-Free SurvivalHospital MortalityHumansLength of StayLung NeoplasmsOperative TimePneumonectomyPostoperative ComplicationsPrognosisThoracic Surgery, Video-AssistedLung cancerMeta-analysisNSCLCVATS segmentectomy

Identifiers

PMID32106856
PMCPMC7047378
OpenAlexW3012272598

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.